- Prev Close
- Today's Open
- Day's Range
- Dollar Volume
- Avg Vol(5-day)
- Avg Vol(1-month)
ViaDerma, Inc. is a pharmaceutical company focused on bringing new products to the pharmaceutical industry through research and development. The Company licenses and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company's products are applied topically using a delivery system technology. The Company's products are used within the over-the-counter (OTC) drug market. In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies. The Company has products in development in various fields, including topical antibiotics (TetraStem), topical anti-viral product (Viralcur) for genital herpes, anti-fungal products for onychomycocis (OnyPro), hair loss prevention product (HairGain), skin cancer therapies (Cantrile), and a topical stem cell therapy product (TetraStem Plus).
Company AddressCEO: Sheng Rui Liu
8950 W. Olympic Blvd
Beverly Hills, CA 90211
Have a suggestion?
Please Contact Us to let us know.
United States Commerce Department Invites ViaDerma to Participate in Official Trade Mission to India
May 15, 2018
ViaDerma, Inc. Enters into a $250,000 Initial Sales Agreement with Vage Nigeria Ltd.
April 24, 2018
ViaDerma, Inc. Provides an Update of Current and Future Product Sales
April 2, 2018
ViaDerma, Inc. Provides an Update of Current Marketing Activities
March 8, 2018
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
March 2, 2018